TCMD:NASDAQTactile Systems Technology, Inc. Analysis
Data as of 2026-08-31 - not real-time
$22.98
Latest Price
8/10Risk
Risk Level: High
Executive Summary
At $22.98, Tactile Systems Technology, Inc. shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has lost 19.1%. With RSI at 33.2 the momentum picture is approaching oversold, alongside a bearish MACD signal. Price has been bracketed by support at $22.73 and resistance at $30.42.
Multiples put this in undervalued territory: 21.5 times earnings against the sector's 30.4. Analyst price targets sit 66.4% above the current price. Revenue is growing at 8.6% on a 7.1% profit margin.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 62.7%, a beta of 0.71 and a maximum drawdown of 32.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.
Multiples put this in undervalued territory: 21.5 times earnings against the sector's 30.4. Analyst price targets sit 66.4% above the current price. Revenue is growing at 8.6% on a 7.1% profit margin.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 62.7%, a beta of 0.71 and a maximum drawdown of 32.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.
Top Market Events
Microsoft Cares About Your Privacy Microsoft and our third-party vendors use cookies to store and access information...; ; ; Continue reading More for You More for You Microsoft Cares About Your Privacy Microsoft and our third-party...MINNEAPOLIS, Aug. 10, 2026 GLOBE NEWSWIRE -- Tactile Systems Technology, Inc. “Tactile Medical”; the “Company”...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 26.95
- MACD momentum is negative
- 30-day price change of -19.1%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 21.5 versus sector average of 30.4
- Trading below the 200-day average of 26.95
- Analyst targets imply +66.4% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 21.5 versus sector average of 30.4
- Analyst targets imply +66.4% versus the current price
- 30-day volatility of 62.7%
Key Metrics & Analysis
Financial Health
Revenue Growth8.60%
Profit Margin7.10%
P/E Ratio21.5
ROE11.88%
ROA7.92%
Debt/Equity6.42
P/B Ratio2.3
Op. Cash Flow$30.6M
Free Cash Flow$14.5M
Industry P/E30.4
Technical Analysis
TrendNeutral
RSI33.2
Support$22.73
Resistance$30.42
MA 20$25.16
MA 50$27.39
MA 200$26.95
MACDBearish
VolumeDecreasing
Fear & Greed Index94.79
Valuation
Fair Value$14.14
Target Price$38.25
Upside/Downside66.45%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.71
Volatility62.74%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.